Galectin89 Induces Maturation of Human Monocyte-derived Dendritic Cells

Japanese Journal of Clinical Immunology

Volumn 28, Issue 6, 2005, Pages 381-388

  Yamauchi, Akira ^a   Dai, Shu Yan ^a   Nakagawa, Ryusuke ^a   Kashio, Yumiko ^a   Abe, Hiroko ^a   Katoh, Shigeki ^a   Kontani, Keiichi ^b   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

cell surface molecules; cellular differentiation; dendritic cells; human; T lymphocytes

Indexed keywords

CYTOKINE; GALECTIN; INTERLEUKIN 12; LEUKOCYTE ANTIGEN; LGALS9 PROTEIN, HUMAN;

ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; DENDRITIC CELL; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GALECTINS; HUMANS; INTERLEUKIN-12; T-LYMPHOCYTES; TH1 CELLS;

EID: 33644848056     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.28.381     Document Type: Article

References (43)

1. Barondes S. H., Castronovo V., Cooper D. N., Cummings R. D., Drickamer K., Feizi T., Gitt M. A., Hirabayashi J., Hughes C., Kasai K., Leffler H., Liu F. T., Lotan R., Mercurio A. M., Monsigny M., Pillai S., Poirer F., Raz A., Rigby P. W., Rini J. M., Wang J.L.: Galectins: a family of animal beta-galactoside-binding lectins. Cell 76: 597–598, 1994.
2. Barondes S. H., Cooper D. N., Gitt M. A., Leffler H.: 1994. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269: 20807–20810, 1994.
3. Asakura H., Kashio Y., Nakamura K., Seki M., Dai S., Shirato Y., Abedin M. J., Yoshida N., Nishi N., Imaizumi T., Saita N., Toyama Y., Takashima H., Nakamura T., Ohkawa M., Hirashima M.: Selective eosinophil adhesion to fibroblast via IFN-γ-induced galectin-9. J. Immunol, 169: 5912–5918, 2002.
4. Nishi N., Shoji H., Seki M., Itoh A., Miyanaka H., Yuube K., Hirashima M., Nakamura T.: Galectin-8 modulates neutrophil function via interaction with integrin αM. Glycobiology 13: 755–763, 2003.
5. Zick Y., Eisenstein M., Goren R. A., Hadari Y. R., Levy Y., Ronen D.: Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj. J. 19: 517–526, 2004.
6. Perillo N. L., Marcus M. E., Baum L.G.: Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76: 402–412, 1998.
7. Perillo N. L., Pace K. E., Seilhamer J. J., Baum L.G.: Apoptosis of T cells mediated by galectin-1. Nature 378: 736–739, 1995.
8. Kashio Y., Nakamura K., Abedin M. J., Seki M., Nishi N., Yoshida N., Nakamura T., Hirashima M.: Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 170: 3631, 3636, 2003.
9. Liu F.T.: Galectins: a new family of regulators of inflammation. Clin. Immunol. 97: 79–88, 2000.
10. Rabinovich G. A., Baum L. G., Tinari N., Paganelli R., Natoli C., Liu F. T., Iacobelli S.: Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23: 313–320, 2002.
11. Almkvist J., Karlsson A.: Galectins as inflammatory mediators. Glycoconjugate J 11: 575–581, 2002.
12. Pioche-Derieu C., Keryer C., Souquere S., Bosq J., Faigle W., Loew D., Hirashima M., Nishi N., Middeldorp J., Busson P.: In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin-9 in membrane raft elements resistant to simvastatin. J Virol 79: 13326–13337, 2005.
13. Kageshita T., Kashio Y., Yamauchi A., Seki M., Abedin M. J., Nishi N., Shoji H., Nakamura T., Ono T., Hirashima M.: Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int. J. Cancer 99: 809–816, 2002.
14. Irie A., Yamauchi A., Kontani K., Kihara M., Liu D., Shirato Y., Seki M., Nishi N., Nakamura T., Yokomise H., Hirashima M.: Galectin-9 as a prognostic factor with anti-metastatic potential in breast cancer. Clin Caner Res 11: 2962–2968, 2005.
15. Abedin M. J., Kashio Y., Seki M., Nakamura K., Hirashima M.: Potential roles of galectins in myeloid differentiation into three different lineages. J Leukoc Biol 73: 650–656, 2003.
16. Dai S. Y., Nakagawa R., Nishi N., Itoh A., Murakami H., Kashio Y., Abe H., Katoh S., Yamanaka T., Hata T., Yamauchi A., Hirashima M.: Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol. 175: 2974–2981, 2005.
17. Arrighi J. F., Rebsamen M., Rousset F., Kindler V., Hauser C.: A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J. Immunol. 166: 3837–3845, 2001.
18. Chabot S., Kashio Y., Seki M., Shirato Y., Nakamura Y., Nishi N., Nakamura T., Matsumoto R., Hirashima M.: Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12: 111–118, 2002.
19. Hirashima M., Ueno M., Saita N., Takamura S., Watanabe K., Tsurufuji S., Adachi M.: Induction of an eosinophil chemotactic factor production from T lymphocytes by a B cell lymphoma line. Immunol. Lett. 36: 273–281, 1993.
20. Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T., Kageshita T., Saita N., Nakamura T.: Galectin-9 in physiological and pathological conditions. Glycoconj. J. 19: 593–600, 2004.
21. Sano H., Hsu D. K., Yu L., Apgar R. J., Kuwabara I., Yamanaka T., Hirashima M., Liu F.T.: Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165: 2156–2164, 2000.
22. Matsumoto R., Matsumoto H., Seki M., Hata M., Asano Y., Kanegasaki S., Stevens R. L., Hirashima M.: Human ecalectin, a variant of human Galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273: 16976–16984, 1998.
23. Horie H., Inagaki Y., Sohma Y., Nozawa R., Okawa K., Hasegawa M., Muramatsu N., Kawano H., Horie M., Koyama H., Sakai I., Takeshita K., Kowada Y., Takano M., Kadoya T.: Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy. J. Neurosci. 19: 9964–9974, 1999.
24. Inagaki Y., Sohma Y., Horie H., Nozawa R., Kadoya T.: Oxidized Galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur. J. Biochem. 267: 2955–2964, 2000.
25. Suk K., Hwang D. Y., Lee M.S.: Natural autoantibody to Galectin-9 in normal human sera. J. Clin. Immunol. 19: 158–165, 1999.
26. Sallusto F., Lanzavecchia A.: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109–1118, 1994.
27. Hokama A., Mizoguchi E., Sugimoto K., Shimomura Y., Tanaka Y., Yoshida M., Rietdijk S. T., de Jong Y. P., Snapper S. B., Terhorst C., Blumberg R. S., Mizoguchi A.: Induced reactivity of intestinal CD4+ T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20: 681–693, 2004.
28. Averbeck M., Braun T., Pfeifer G., Sleeman J., Dudda J., Martin S. F., Kremer B., Aktories K., Simon J. C., Termeer C.: Early cytoskeletal rearrangement during dendritic cell maturation enhances synapse formation and Ca2+ signaling in CD8+ T cells. Eur. J. Immunol. 34: 2708–2719, 2004.
29. Kalinski P., Hilkens C. M., Snijders A., Snijdewint F. G., Kapsenberg M.L.: IL-12-deficient dendritic cells, generated in the presence of prostaglan-din E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28–35, 1997.
30. Banchereau J., Steinman R.M.: Dendritic cells and the control of immunity. Nature 392: 245–252, 1998.
31. Verdijk R. M., Mutis T., Esendam B., Kamp J., Melief C. J., Brand A., Goulmy E.: Polyriboinosinic polyribocytidylic acid (poly (I: C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163: 57–61, 1999.
32. Bender A., Sapp M., Schuler G., Steinman R. M., Bhardwaj N.: Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196: 121–135, 1996.
33. Luft T., Pang K. C., Thomas E., Hertzog P., Hart D. N., Trapani J., Cebon J.: Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161: 1947–1953, 1998.
34. Ishikawa A., Imaizumi T., Yoshida H., Nishi N., Nakamura T., Hirashima M., Satoh K.: Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells. Immunol. Cell Biol. 82: 410–414, 2004.
35. Yoshida H., Imaizumi T., Kumagai M., Kimura K., Satoh C., Hanada N., Fujimoto K., Nishi N., Tanji K., Matsumiya T., Mori F., Cui X. F., Tamo W., Shibata T., Takanashi S., Okumura K., Nakamura T., Wakabayashi K., Hirashima M., Sato Y., Satoh K.: Interleukin-1beta stimulates galectin-9 expression in human astrocytes. Neuro Report 12: 3755–3758, 2001.
36. Steinman R. M., Witmer-Pack M., Inaba K.: Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329: 1–9, 1993.
37. Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von den Driesch P., Brocker E. B., Steinman R. M., Enk A., Kampgen E., Schuler G.: Vaccination with mage-3A1 peptidepulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669–1678, 1999.
38. Engleman, E.G.: Dendritic cell-based cancer immunotherapy. Semin. Oncol. 30:23–29, 2003.
39. Figdor C. G., de Vries I. J., Lesterhuis W. J., Melief C.J.: Dendritic cell immunotherapy: mapping the way. Nat Med. 10: 475–480, 2004.
40. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S.: Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med. 4: 594–600, 1998.
41. Chaput, N., F. Andre, N. E. Schartz, C. Flament, E. Angevin, B. Escudier, and L. Zitvogel.: Exosomes anti-tumour immunotherapy. Bull. Cancer 90: 695, 2003.
42. Andre F., Andersen M., Wolfers J., Lozier A., Raposo G., Serra V., Ruegg C., Flament C., Angevin E., Amigorena S., Zitvogel L.: Exosomes in cancer immunotherapy: preclinical data. Adv. Exp. Med. Biol. 495: 349–352, 2001.
43. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., Amigorena S.: Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166:7309–7318,2001.